Epidermal pseudocarcinomatous hyperplasia with underlying epidermal growth factor-producing cutaneous CD30-positive lymphoproliferative disorder. 2009

Y Kawachi, and S Taguchi, and Y Fujisawa, and J Furuta, and Y Nakamura, and Y Ishii, and T Takahashi, and F Otsuka

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D008232 Lymphoproliferative Disorders Disorders characterized by proliferation of lymphoid tissue, general or unspecified. Duncan's Syndrome,X-Linked Lymphoproliferative Syndrome,Duncan Disease,Epstein-Barr Virus Infection, Familial Fatal,Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males,Familial Fatal Epstein-Barr Infection,Immunodeficiency 5,Immunodeficiency, X-Linked Progressive Combined Variable,Lymphoproliferative Disease, X-Linked,Lymphoproliferative Syndrome, X-Linked, 1,Purtilo Syndrome,X-Linked Lymphoproliferative Disease,X-Linked Lymphoproliferative Disorder,Disease, Duncan,Disease, X-Linked Lymphoproliferative,Diseases, X-Linked Lymphoproliferative,Disorder, Lymphoproliferative,Disorder, X-Linked Lymphoproliferative,Disorders, Lymphoproliferative,Disorders, X-Linked Lymphoproliferative,Epstein Barr Virus Induced Lymphoproliferative Disease In Males,Epstein Barr Virus Infection, Familial Fatal,Familial Fatal Epstein Barr Infection,Immunodeficiency 5s,Immunodeficiency, X Linked Progressive Combined Variable,Lymphoproliferative Disease, X Linked,Lymphoproliferative Diseases, X-Linked,Lymphoproliferative Disorder,Lymphoproliferative Disorder, X-Linked,Lymphoproliferative Disorders, X-Linked,Lymphoproliferative Syndrome, X-Linked,Lymphoproliferative Syndromes, X-Linked,Purtilo Syndromes,Syndrome, Purtilo,Syndrome, X-Linked Lymphoproliferative,Syndromes, Purtilo,Syndromes, X-Linked Lymphoproliferative,X Linked Lymphoproliferative Disease,X Linked Lymphoproliferative Disorder,X Linked Lymphoproliferative Syndrome,X-Linked Lymphoproliferative Diseases,X-Linked Lymphoproliferative Disorders,X-Linked Lymphoproliferative Syndromes
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease
D017730 Ki-1 Antigen A member of the tumor necrosis factor receptor superfamily that may play a role in the regulation of NF-KAPPA B and APOPTOSIS. It is found on activated T-LYMPHOCYTES; B-LYMPHOCYTES; NEUTROPHILS; EOSINOPHILS; MAST CELLS and NK CELLS. Overexpression of the Ki-1 antigen in hematopoietic malignancies make it clinically useful as a biological tumor marker. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS. Antigens, CD30,Antigens, Ki-1,Ber-H2 Antigens,CD30 Antigens,Ki-1 Antigens,Tumor Necrosis Factor Receptor Superfamily, Member 8,Ber-H2 Antigen,CD30 Antigen,TNFRSF8 Receptor,Antigen, Ber-H2,Antigen, CD30,Antigen, Ki-1,Antigens, Ber-H2,Antigens, Ki 1,Ber H2 Antigen,Ber H2 Antigens,Ki 1 Antigen,Ki 1 Antigens,Receptor, TNFRSF8

Related Publications

Y Kawachi, and S Taguchi, and Y Fujisawa, and J Furuta, and Y Nakamura, and Y Ishii, and T Takahashi, and F Otsuka
July 2018, Clinical and experimental dermatology,
Y Kawachi, and S Taguchi, and Y Fujisawa, and J Furuta, and Y Nakamura, and Y Ishii, and T Takahashi, and F Otsuka
June 2014, Surgical pathology clinics,
Y Kawachi, and S Taguchi, and Y Fujisawa, and J Furuta, and Y Nakamura, and Y Ishii, and T Takahashi, and F Otsuka
March 2015, Journal of the American Academy of Dermatology,
Y Kawachi, and S Taguchi, and Y Fujisawa, and J Furuta, and Y Nakamura, and Y Ishii, and T Takahashi, and F Otsuka
December 2003, Hematology/oncology clinics of North America,
Y Kawachi, and S Taguchi, and Y Fujisawa, and J Furuta, and Y Nakamura, and Y Ishii, and T Takahashi, and F Otsuka
December 2023, The American Journal of dermatopathology,
Y Kawachi, and S Taguchi, and Y Fujisawa, and J Furuta, and Y Nakamura, and Y Ishii, and T Takahashi, and F Otsuka
October 2021, Leukemia & lymphoma,
Y Kawachi, and S Taguchi, and Y Fujisawa, and J Furuta, and Y Nakamura, and Y Ishii, and T Takahashi, and F Otsuka
May 2002, Journal of cutaneous pathology,
Y Kawachi, and S Taguchi, and Y Fujisawa, and J Furuta, and Y Nakamura, and Y Ishii, and T Takahashi, and F Otsuka
January 2022, JID innovations : skin science from molecules to population health,
Y Kawachi, and S Taguchi, and Y Fujisawa, and J Furuta, and Y Nakamura, and Y Ishii, and T Takahashi, and F Otsuka
May 2011, Journal of pediatric hematology/oncology,
Y Kawachi, and S Taguchi, and Y Fujisawa, and J Furuta, and Y Nakamura, and Y Ishii, and T Takahashi, and F Otsuka
January 2012, European journal of dermatology : EJD,
Copied contents to your clipboard!